Management of dyslipidemia in HIV-infected patients.
Management of dyslipidemia in HIV-infected patients.
Clin Lipidol. 2011 Aug;6(4):447-462
Authors: Malvestutto CD, Aberg JA
Abstract
Antiretroviral therapy has dramatically increased survival for HIV-infected individuals. As this population lives longer, coronary heart disease has become an important comorbid condition. Dyslipidemia in HIV-infected individuals is a complex condition, with multiple contributing factors including the HIV virus itself, individual genetic characteristics and antiretroviral therapy-induced metabolic changes. Effective management of dyslipidemia in this population is essential to reduce cardiovascular risk but presents multiple challenges due to interactions between antiretroviral therapy agents and lipid-lowering medications.
PMID: 22216062 [PubMed - as supplied by publisher]
Source: Clinical Lipidology - Category: Lipidology Tags: Clin Lipidol Source Type: research
More News: Cardiology | Cardiovascular | Coronary Heart Disease | Genetics | Heart | Heart Disease | Lipidology